beta
Trial Radar AI
I can help you find nearby clinical trials and understand health conditions and treatments.
39 Results
 
Status (Default)
Not yet Recruiting, Recruiting, Active, Not Recruiting
×
 
Keywords
Type 2 Diabetes, GLP-1
×
 
Phase
Phase 2
×
 
Intervention
GLP-1
×
 
Study Title
Status
The Role of Islet GLP-1 in the Pathogenesis of Prediabetes NCT06967558
Recruiting
The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes NCT06976619
Recruiting
The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans NCT06972407
Not yet recruiting
GLP-1 RA for Stage 1 Type 1 Diabetes NCT07430332
Not yet recruiting
Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment NCT06411210
Recruiting
A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM (VESPER-2) NCT06897202
Active, not recruiting
Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist (ARAY) NCT06851858
Active, not recruiting
Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants NCT06737042
Not yet recruiting
Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide (SEMA SMA) NCT06387199
Recruiting
A Study to Compare the Efficacy and Safety of GZR102 Injection and GZR18 Injection in Type 2 Diabetes Mellitus NCT07055386
Active, not recruiting
The Medically Reproducing Bariatric Surgery (MRB) II Study NCT06363747
Active, not recruiting
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy NCT07502508
Recruiting
Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes (TIRTLE2) NCT06820281
Not yet recruiting
Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults NCT06811324
Recruiting
Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity NCT07497880
Not yet recruiting
Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity (TZP-T1D) NCT06180616
Not yet recruiting
The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients (HALLMARK) NCT05938712
Recruiting
Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder (DUALPSYCHIATRY) NCT06939088
Recruiting
A Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or Overweight (VESPER-3) NCT06973720
Active, not recruiting
A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes NCT06924320
Recruiting
The Effects of Glucagon on Hepatic Metabolism NCT05500586
Active, not recruiting
The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction NCT05499702
Recruiting
A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar (TZP) NCT07284511
Not yet recruiting
Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight (GZBF) NCT07467447
Recruiting
Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY) NCT07029009
Recruiting
Triple Therapy in T1DM NCT03899402
Active, not recruiting
Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB) NCT07292519
Not yet recruiting
Effects of GRA in Patients With Type 1 NCT04779645
Active, not recruiting
Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus NCT05268237
Recruiting
Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3) NCT05254314
Recruiting
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity NCT05912621
Recruiting
A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity NCT06037252
Active, not recruiting
Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances in Type 1 Diabetes (SOTA) NCT05696366
Recruiting
A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes NCT06603571
Active, not recruiting
A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes (TREASURE-CKD) NCT05536804
Active, not recruiting
Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes NCT06762314
Recruiting
Study of ARO-INHBE in Adults With Obesity With and Without Diabetes Mellitus NCT06700538
Recruiting
A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight NCT06643728
Active, not recruiting
Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV NCT06935838
Recruiting